Doxorubicin-induced oxidative injury of cardiomyocytes - do we have right strategies for prevention?
Anthracyclines are among the most utilised antitumour drugs ever developed. The discovery of one of the leading compounds, doxorubicin (DOX) in early 1960s was a major advance in the fight against cancer. According to the WHO, it belongs to the group of 17 essential drugs that are used to treat cura...
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | bookPart |
| Idioma: | eng |
| Publicado em: |
2012
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.18/665 |
| País: | Portugal |
| Oai: | oai:repositorio.insa.pt:10400.18/665 |